nodes	percent_of_prediction	percent_of_DWPC	metapath
Reboxetine—HTR2C—bipolar disorder	0.482	0.547	CbGaD
Reboxetine—SLC6A4—bipolar disorder	0.4	0.453	CbGaD
Reboxetine—SLC6A2—locus ceruleus—bipolar disorder	0.0145	0.259	CbGeAlD
Reboxetine—HTR2C—telencephalic ventricle—bipolar disorder	0.00821	0.147	CbGeAlD
Reboxetine—SLC6A2—autonomic nervous system—bipolar disorder	0.00768	0.138	CbGeAlD
Reboxetine—SLC6A4—blood plasma—bipolar disorder	0.00371	0.0666	CbGeAlD
Reboxetine—CYP3A4—urine—bipolar disorder	0.00348	0.0625	CbGeAlD
Reboxetine—CYP2D6—urine—bipolar disorder	0.00343	0.0615	CbGeAlD
Reboxetine—CYP3A4—blood plasma—bipolar disorder	0.00182	0.0326	CbGeAlD
Reboxetine—CYP2D6—blood plasma—bipolar disorder	0.00179	0.0321	CbGeAlD
Reboxetine—Orphenadrine—GRIN1—bipolar disorder	0.00152	0.278	CrCbGaD
Reboxetine—ABCB1—blood plasma—bipolar disorder	0.00129	0.0231	CbGeAlD
Reboxetine—Diphenylpyraline—SLC6A3—bipolar disorder	0.00118	0.216	CrCbGaD
Reboxetine—HTR2C—nervous system—bipolar disorder	0.00116	0.0209	CbGeAlD
Reboxetine—SLC6A4—nervous system—bipolar disorder	0.0011	0.0198	CbGeAlD
Reboxetine—SLC6A2—nervous system—bipolar disorder	0.000971	0.0174	CbGeAlD
Reboxetine—Benzatropine—SLC6A3—bipolar disorder	0.000905	0.166	CrCbGaD
Reboxetine—HTR2C—brain—bipolar disorder	0.00089	0.016	CbGeAlD
Reboxetine—SLC6A4—brain—bipolar disorder	0.000843	0.0151	CbGeAlD
Reboxetine—SLC6A2—brain—bipolar disorder	0.000743	0.0133	CbGeAlD
Reboxetine—SLC6A4—Synaptic Vesicle Pathway—SNAP25—bipolar disorder	0.00069	0.0122	CbGpPWpGaD
Reboxetine—HTR2C—Monoamine GPCRs—DRD1—bipolar disorder	0.000677	0.012	CbGpPWpGaD
Reboxetine—HTR2C—Monoamine GPCRs—DRD3—bipolar disorder	0.000656	0.0116	CbGpPWpGaD
Reboxetine—ABCB1—adrenal cortex—bipolar disorder	0.000653	0.0117	CbGeAlD
Reboxetine—HTR2C—Monoamine GPCRs—DRD4—bipolar disorder	0.000637	0.0113	CbGpPWpGaD
Reboxetine—SLC6A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC5A3—bipolar disorder	0.00063	0.0111	CbGpPWpGaD
Reboxetine—HTR2C—Serotonin Receptor 2 and ELK-SRF/GATA4 signaling—HTR2A—bipolar disorder	0.00062	0.011	CbGpPWpGaD
Reboxetine—HTR2C—Monoamine GPCRs—DRD2—bipolar disorder	0.000593	0.0105	CbGpPWpGaD
Reboxetine—HTR2C—Amine ligand-binding receptors—HTR1A—bipolar disorder	0.000589	0.0104	CbGpPWpGaD
Reboxetine—HTR2C—GPCRs, Class A Rhodopsin-like—GPR50—bipolar disorder	0.000583	0.0103	CbGpPWpGaD
Reboxetine—Atomoxetine—SLC6A3—bipolar disorder	0.000576	0.106	CrCbGaD
Reboxetine—HTR2C—Amine ligand-binding receptors—DRD1—bipolar disorder	0.000569	0.0101	CbGpPWpGaD
Reboxetine—HTR2C—Amine ligand-binding receptors—DRD3—bipolar disorder	0.000551	0.00976	CbGpPWpGaD
Reboxetine—CYP3A4—nervous system—bipolar disorder	0.000541	0.00971	CbGeAlD
Reboxetine—HTR2C—Amine ligand-binding receptors—DRD4—bipolar disorder	0.000535	0.00947	CbGpPWpGaD
Reboxetine—CYP2D6—nervous system—bipolar disorder	0.000532	0.00955	CbGeAlD
Reboxetine—SLC6A4—NRF2 pathway—SLC5A3—bipolar disorder	0.000528	0.00934	CbGpPWpGaD
Reboxetine—Atomoxetine—HTR2C—bipolar disorder	0.00052	0.0953	CrCbGaD
Reboxetine—CYP2D6—cerebellum—bipolar disorder	0.000501	0.00899	CbGeAlD
Reboxetine—HTR2C—Amine ligand-binding receptors—DRD2—bipolar disorder	0.000499	0.00883	CbGpPWpGaD
Reboxetine—CYP2D6—Melatonin metabolism and effects—CLOCK—bipolar disorder	0.000496	0.00878	CbGpPWpGaD
Reboxetine—ABCB1—thyroid gland—bipolar disorder	0.000455	0.00817	CbGeAlD
Reboxetine—SLC6A2—NRF2 pathway—SLC5A3—bipolar disorder	0.000454	0.00804	CbGpPWpGaD
Reboxetine—SLC6A4—Circadian rythm related genes—NR1D1—bipolar disorder	0.000436	0.00772	CbGpPWpGaD
Reboxetine—Atomoxetine—SLC6A4—bipolar disorder	0.000431	0.0789	CrCbGaD
Reboxetine—HTR2C—Monoamine GPCRs—HTR2A—bipolar disorder	0.000415	0.00735	CbGpPWpGaD
Reboxetine—CYP2D6—brain—bipolar disorder	0.000407	0.0073	CbGeAlD
Reboxetine—SLC6A4—SIDS Susceptibility Pathways—GRIN1—bipolar disorder	0.000387	0.00686	CbGpPWpGaD
Reboxetine—ABCB1—nervous system—bipolar disorder	0.000383	0.00687	CbGeAlD
Reboxetine—SLC6A4—Monoamine Transport—IL1B—bipolar disorder	0.000364	0.00644	CbGpPWpGaD
Reboxetine—ABCB1—cerebellum—bipolar disorder	0.00036	0.00647	CbGeAlD
Reboxetine—SLC6A4—SIDS Susceptibility Pathways—TPH2—bipolar disorder	0.000353	0.00624	CbGpPWpGaD
Reboxetine—SLC6A4—SIDS Susceptibility Pathways—TACR1—bipolar disorder	0.000353	0.00624	CbGpPWpGaD
Reboxetine—SLC6A4—NRF2 pathway—SERPINA1—bipolar disorder	0.00035	0.00619	CbGpPWpGaD
Reboxetine—HTR2C—Amine ligand-binding receptors—HTR2A—bipolar disorder	0.000349	0.00618	CbGpPWpGaD
Reboxetine—Atomoxetine—HTR2A—bipolar disorder	0.000331	0.0607	CrCbGaD
Reboxetine—HTR2C—G alpha (q) signalling events—DGKH—bipolar disorder	0.000328	0.00581	CbGpPWpGaD
Reboxetine—SLC6A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A3—bipolar disorder	0.000316	0.00559	CbGpPWpGaD
Reboxetine—SLC6A2—Monoamine Transport—IL1B—bipolar disorder	0.000313	0.00554	CbGpPWpGaD
Reboxetine—SLC6A2—NRF2 pathway—SERPINA1—bipolar disorder	0.000301	0.00532	CbGpPWpGaD
Reboxetine—SLC6A4—Circadian rythm related genes—CLOCK—bipolar disorder	0.000296	0.00523	CbGpPWpGaD
Reboxetine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—DGKH—bipolar disorder	0.000294	0.0052	CbGpPWpGaD
Reboxetine—ABCB1—brain—bipolar disorder	0.000292	0.00525	CbGeAlD
Reboxetine—SLC6A4—SIDS Susceptibility Pathways—HTR1A—bipolar disorder	0.000292	0.00517	CbGpPWpGaD
Reboxetine—CYP2D6—Melatonin metabolism and effects—MAOA—bipolar disorder	0.000291	0.00515	CbGpPWpGaD
Reboxetine—SLC6A4—Circadian rythm related genes—TPH2—bipolar disorder	0.000288	0.0051	CbGpPWpGaD
Reboxetine—SLC6A4—SIDS Susceptibility Pathways—TAC1—bipolar disorder	0.000288	0.00509	CbGpPWpGaD
Reboxetine—SLC6A2—SLC-mediated transmembrane transport—SLC5A3—bipolar disorder	0.000286	0.00506	CbGpPWpGaD
Reboxetine—SLC6A4—SIDS Susceptibility Pathways—GATA3—bipolar disorder	0.000282	0.00499	CbGpPWpGaD
Reboxetine—SLC6A4—SIDS Susceptibility Pathways—SNAP25—bipolar disorder	0.000282	0.00499	CbGpPWpGaD
Reboxetine—CYP3A4—Estrogen metabolism—COMT—bipolar disorder	0.000281	0.00497	CbGpPWpGaD
Reboxetine—SLC6A4—SIDS Susceptibility Pathways—NTRK2—bipolar disorder	0.000274	0.00486	CbGpPWpGaD
Reboxetine—ABCB1—HIF-1-alpha transcription factor network—ADM—bipolar disorder	0.000273	0.00483	CbGpPWpGaD
Reboxetine—SLC6A4—NRF2 pathway—SLC6A3—bipolar disorder	0.000265	0.00469	CbGpPWpGaD
Reboxetine—SLC6A2—NRF2 pathway—SLC6A4—bipolar disorder	0.000256	0.00453	CbGpPWpGaD
Reboxetine—SLC6A2—Transmembrane transport of small molecules—TRPM2—bipolar disorder	0.000253	0.00448	CbGpPWpGaD
Reboxetine—HTR2C—GPCRs, Class A Rhodopsin-like—DRD5—bipolar disorder	0.000232	0.00411	CbGpPWpGaD
Reboxetine—SLC6A4—Circadian rythm related genes—DRD1—bipolar disorder	0.00023	0.00408	CbGpPWpGaD
Reboxetine—SLC6A2—NRF2 pathway—SLC6A3—bipolar disorder	0.000228	0.00403	CbGpPWpGaD
Reboxetine—HTR2C—G alpha (q) signalling events—TRPC3—bipolar disorder	0.000227	0.00403	CbGpPWpGaD
Reboxetine—SLC6A4—Circadian rythm related genes—DRD3—bipolar disorder	0.000223	0.00395	CbGpPWpGaD
Reboxetine—SLC6A4—Circadian rythm related genes—DRD4—bipolar disorder	0.000216	0.00383	CbGpPWpGaD
Reboxetine—SLC6A4—SIDS Susceptibility Pathways—MAOA—bipolar disorder	0.000212	0.00376	CbGpPWpGaD
Reboxetine—HTR2C—G alpha (q) signalling events—TACR1—bipolar disorder	0.000211	0.00374	CbGpPWpGaD
Reboxetine—SLC6A4—SIDS Susceptibility Pathways—BDNF—bipolar disorder	0.000205	0.00362	CbGpPWpGaD
Reboxetine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—TRPC3—bipolar disorder	0.000203	0.0036	CbGpPWpGaD
Reboxetine—SLC6A4—NRF2 pathway—NRG1—bipolar disorder	0.000202	0.00358	CbGpPWpGaD
Reboxetine—SLC6A4—Circadian rythm related genes—DRD2—bipolar disorder	0.000202	0.00357	CbGpPWpGaD
Reboxetine—HTR2C—Class A/1 (Rhodopsin-like receptors)—DRD5—bipolar disorder	0.000199	0.00352	CbGpPWpGaD
Reboxetine—CYP2D6—Metapathway biotransformation—AKR1C4—bipolar disorder	0.000194	0.00343	CbGpPWpGaD
Reboxetine—CYP2D6—Melatonin metabolism and effects—GSK3B—bipolar disorder	0.000191	0.00338	CbGpPWpGaD
Reboxetine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—TACR1—bipolar disorder	0.000189	0.00335	CbGpPWpGaD
Reboxetine—SLC6A4—Circadian rythm related genes—NTRK1—bipolar disorder	0.000183	0.00323	CbGpPWpGaD
Reboxetine—SLC6A4—SIDS Susceptibility Pathways—NR3C1—bipolar disorder	0.000181	0.0032	CbGpPWpGaD
Reboxetine—SLC6A2—NRF2 pathway—NRG1—bipolar disorder	0.000174	0.00308	CbGpPWpGaD
Reboxetine—SLC6A4—SIDS Susceptibility Pathways—HTR2A—bipolar disorder	0.000173	0.00306	CbGpPWpGaD
Reboxetine—HTR2C—G alpha (q) signalling events—TAC1—bipolar disorder	0.000172	0.00305	CbGpPWpGaD
Reboxetine—ABCB1—Allograft Rejection—HLA-E—bipolar disorder	0.00017	0.00301	CbGpPWpGaD
Reboxetine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—bipolar disorder	0.000154	0.00273	CbGpPWpGaD
Reboxetine—HTR2C—GPCR ligand binding—DRD5—bipolar disorder	0.000151	0.00268	CbGpPWpGaD
Reboxetine—SLC6A2—Transmembrane transport of small molecules—SLC5A3—bipolar disorder	0.000145	0.00257	CbGpPWpGaD
Reboxetine—SLC6A2—SLC-mediated transmembrane transport—SLC6A3—bipolar disorder	0.000144	0.00254	CbGpPWpGaD
Reboxetine—HTR2C—Class A/1 (Rhodopsin-like receptors)—TSHB—bipolar disorder	0.00014	0.00248	CbGpPWpGaD
Reboxetine—HTR2C—Class A/1 (Rhodopsin-like receptors)—TACR1—bipolar disorder	0.00014	0.00248	CbGpPWpGaD
Reboxetine—HTR2C—GPCRs, Class A Rhodopsin-like—HTR1A—bipolar disorder	0.000135	0.0024	CbGpPWpGaD
Reboxetine—CYP2D6—Phase 1 - Functionalization of compounds—MAOA—bipolar disorder	0.000132	0.00233	CbGpPWpGaD
Reboxetine—HTR2C—GPCRs, Class A Rhodopsin-like—DRD1—bipolar disorder	0.000131	0.00231	CbGpPWpGaD
Reboxetine—HTR2C—GPCRs, Class A Rhodopsin-like—DRD3—bipolar disorder	0.000127	0.00224	CbGpPWpGaD
Reboxetine—CYP3A4—Metapathway biotransformation—AKR1C4—bipolar disorder	0.000127	0.00224	CbGpPWpGaD
Reboxetine—HTR2C—GPCRs, Class A Rhodopsin-like—DRD4—bipolar disorder	0.000123	0.00218	CbGpPWpGaD
Reboxetine—HTR2C—Class A/1 (Rhodopsin-like receptors)—HTR1A—bipolar disorder	0.000116	0.00205	CbGpPWpGaD
Reboxetine—HTR2C—GPCRs, Class A Rhodopsin-like—DRD2—bipolar disorder	0.000114	0.00203	CbGpPWpGaD
Reboxetine—HTR2C—Class A/1 (Rhodopsin-like receptors)—TAC1—bipolar disorder	0.000114	0.00202	CbGpPWpGaD
Reboxetine—SLC6A4—Circadian rythm related genes—GSK3B—bipolar disorder	0.000114	0.00201	CbGpPWpGaD
Reboxetine—HTR2C—Class A/1 (Rhodopsin-like receptors)—DRD1—bipolar disorder	0.000112	0.00198	CbGpPWpGaD
Reboxetine—ABCB1—Transmembrane transport of small molecules—TRPM2—bipolar disorder	0.000111	0.00197	CbGpPWpGaD
Reboxetine—SLC6A2—Transmembrane transport of small molecules—TRPC3—bipolar disorder	0.00011	0.00195	CbGpPWpGaD
Reboxetine—HTR2C—GPCR ligand binding—ADM—bipolar disorder	0.000109	0.00194	CbGpPWpGaD
Reboxetine—HTR2C—Class A/1 (Rhodopsin-like receptors)—DRD3—bipolar disorder	0.000108	0.00192	CbGpPWpGaD
Reboxetine—HTR2C—GPCR ligand binding—TSHB—bipolar disorder	0.000107	0.00189	CbGpPWpGaD
Reboxetine—HTR2C—GPCR ligand binding—TACR1—bipolar disorder	0.000107	0.00189	CbGpPWpGaD
Reboxetine—CYP2D6—Cytochrome P450 - arranged by substrate type—POMC—bipolar disorder	0.000106	0.00187	CbGpPWpGaD
Reboxetine—HTR2C—Class A/1 (Rhodopsin-like receptors)—DRD4—bipolar disorder	0.000105	0.00186	CbGpPWpGaD
Reboxetine—HTR2C—G alpha (q) signalling events—HTR2A—bipolar disorder	0.000104	0.00184	CbGpPWpGaD
Reboxetine—SLC6A4—SIDS Susceptibility Pathways—IL1B—bipolar disorder	0.000103	0.00181	CbGpPWpGaD
Reboxetine—HTR2C—Class A/1 (Rhodopsin-like receptors)—DRD2—bipolar disorder	9.81e-05	0.00174	CbGpPWpGaD
Reboxetine—HTR2C—GPCR downstream signaling—DGKH—bipolar disorder	9.35e-05	0.00166	CbGpPWpGaD
Reboxetine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—bipolar disorder	9.28e-05	0.00164	CbGpPWpGaD
Reboxetine—HTR2C—GPCR ligand binding—HTR1A—bipolar disorder	8.83e-05	0.00156	CbGpPWpGaD
Reboxetine—ABCB1—Integrated Pancreatic Cancer Pathway—GSK3A—bipolar disorder	8.76e-05	0.00155	CbGpPWpGaD
Reboxetine—HTR2C—GPCR ligand binding—TAC1—bipolar disorder	8.7e-05	0.00154	CbGpPWpGaD
Reboxetine—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—bipolar disorder	8.62e-05	0.00153	CbGpPWpGaD
Reboxetine—CYP2D6—Phase 1 - Functionalization of compounds—POMC—bipolar disorder	8.58e-05	0.00152	CbGpPWpGaD
Reboxetine—HTR2C—GPCR downstream signaling—DRD5—bipolar disorder	8.56e-05	0.00151	CbGpPWpGaD
Reboxetine—HTR2C—GPCR ligand binding—DRD1—bipolar disorder	8.53e-05	0.00151	CbGpPWpGaD
Reboxetine—HTR2C—Signaling by GPCR—DGKH—bipolar disorder	8.49e-05	0.0015	CbGpPWpGaD
Reboxetine—HTR2C—GPCR downstream signaling—RGS4—bipolar disorder	8.39e-05	0.00149	CbGpPWpGaD
Reboxetine—HTR2C—GPCR ligand binding—DRD3—bipolar disorder	8.26e-05	0.00146	CbGpPWpGaD
Reboxetine—HTR2C—GPCRs, Class A Rhodopsin-like—HTR2A—bipolar disorder	8.02e-05	0.00142	CbGpPWpGaD
Reboxetine—HTR2C—GPCR ligand binding—DRD4—bipolar disorder	8.02e-05	0.00142	CbGpPWpGaD
Reboxetine—HTR2C—Signaling by GPCR—DRD5—bipolar disorder	7.77e-05	0.00138	CbGpPWpGaD
Reboxetine—HTR2C—Signaling by GPCR—RGS4—bipolar disorder	7.62e-05	0.00135	CbGpPWpGaD
Reboxetine—HTR2C—GPCR ligand binding—DRD2—bipolar disorder	7.47e-05	0.00132	CbGpPWpGaD
Reboxetine—SLC6A2—Transmembrane transport of small molecules—SLC6A3—bipolar disorder	7.3e-05	0.00129	CbGpPWpGaD
Reboxetine—SLC6A2—Transmembrane transport of small molecules—ADCY2—bipolar disorder	7.25e-05	0.00128	CbGpPWpGaD
Reboxetine—ABCB1—Integrated Pancreatic Cancer Pathway—NTRK1—bipolar disorder	7.2e-05	0.00127	CbGpPWpGaD
Reboxetine—CYP2D6—Biological oxidations—COMT—bipolar disorder	7.05e-05	0.00125	CbGpPWpGaD
Reboxetine—CYP2D6—Biological oxidations—MAOA—bipolar disorder	7e-05	0.00124	CbGpPWpGaD
Reboxetine—CYP2D6—Metapathway biotransformation—COMT—bipolar disorder	6.96e-05	0.00123	CbGpPWpGaD
Reboxetine—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—bipolar disorder	6.92e-05	0.00123	CbGpPWpGaD
Reboxetine—HTR2C—Class A/1 (Rhodopsin-like receptors)—HTR2A—bipolar disorder	6.87e-05	0.00122	CbGpPWpGaD
Reboxetine—ABCB1—Allograft Rejection—IL1B—bipolar disorder	6.69e-05	0.00118	CbGpPWpGaD
Reboxetine—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—bipolar disorder	6.59e-05	0.00117	CbGpPWpGaD
Reboxetine—HTR2C—GPCR downstream signaling—TRPC3—bipolar disorder	6.48e-05	0.00115	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—IMPA2—bipolar disorder	6.4e-05	0.00113	CbGpPWpGaD
Reboxetine—ABCB1—Transmembrane transport of small molecules—SLC5A3—bipolar disorder	6.4e-05	0.00113	CbGpPWpGaD
Reboxetine—HTR2C—GPCR downstream signaling—ADM—bipolar disorder	6.19e-05	0.00109	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—IMPA2—bipolar disorder	6.04e-05	0.00107	CbGpPWpGaD
Reboxetine—HTR2C—GPCR downstream signaling—TSHB—bipolar disorder	6.03e-05	0.00107	CbGpPWpGaD
Reboxetine—HTR2C—GPCR downstream signaling—PDE4B—bipolar disorder	6.03e-05	0.00107	CbGpPWpGaD
Reboxetine—HTR2C—GPCR downstream signaling—TACR1—bipolar disorder	6.03e-05	0.00107	CbGpPWpGaD
Reboxetine—HTR2C—Signaling by GPCR—TRPC3—bipolar disorder	5.89e-05	0.00104	CbGpPWpGaD
Reboxetine—HTR2C—Signaling by GPCR—ADM—bipolar disorder	5.62e-05	0.000994	CbGpPWpGaD
Reboxetine—CYP3A4—Phase 1 - Functionalization of compounds—POMC—bipolar disorder	5.61e-05	0.000993	CbGpPWpGaD
Reboxetine—HTR2C—Class A/1 (Rhodopsin-like receptors)—POMC—bipolar disorder	5.49e-05	0.000971	CbGpPWpGaD
Reboxetine—HTR2C—Signaling by GPCR—TSHB—bipolar disorder	5.47e-05	0.000969	CbGpPWpGaD
Reboxetine—HTR2C—Signaling by GPCR—PDE4B—bipolar disorder	5.47e-05	0.000969	CbGpPWpGaD
Reboxetine—HTR2C—Signaling by GPCR—TACR1—bipolar disorder	5.47e-05	0.000969	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—AKR1C4—bipolar disorder	5.45e-05	0.000965	CbGpPWpGaD
Reboxetine—HTR2C—GPCR ligand binding—HTR2A—bipolar disorder	5.23e-05	0.000926	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—DGKH—bipolar disorder	5.02e-05	0.000888	CbGpPWpGaD
Reboxetine—HTR2C—GPCR downstream signaling—HTR1A—bipolar disorder	4.99e-05	0.000883	CbGpPWpGaD
Reboxetine—HTR2C—GPCR downstream signaling—TAC1—bipolar disorder	4.91e-05	0.00087	CbGpPWpGaD
Reboxetine—ABCB1—Transmembrane transport of small molecules—TRPC3—bipolar disorder	4.85e-05	0.000859	CbGpPWpGaD
Reboxetine—HTR2C—GPCR downstream signaling—DRD1—bipolar disorder	4.82e-05	0.000853	CbGpPWpGaD
Reboxetine—HTR2C—GPCR downstream signaling—DRD3—bipolar disorder	4.67e-05	0.000826	CbGpPWpGaD
Reboxetine—CYP3A4—Biological oxidations—COMT—bipolar disorder	4.61e-05	0.000816	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—DRD5—bipolar disorder	4.59e-05	0.000812	CbGpPWpGaD
Reboxetine—CYP3A4—Biological oxidations—MAOA—bipolar disorder	4.58e-05	0.00081	CbGpPWpGaD
Reboxetine—CYP2D6—Biological oxidations—POMC—bipolar disorder	4.56e-05	0.000807	CbGpPWpGaD
Reboxetine—CYP3A4—Metapathway biotransformation—COMT—bipolar disorder	4.55e-05	0.000805	CbGpPWpGaD
Reboxetine—HTR2C—Signaling by GPCR—HTR1A—bipolar disorder	4.53e-05	0.000802	CbGpPWpGaD
Reboxetine—HTR2C—GPCR downstream signaling—DRD4—bipolar disorder	4.53e-05	0.000802	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—RGS4—bipolar disorder	4.5e-05	0.000797	CbGpPWpGaD
Reboxetine—HTR2C—Signaling by GPCR—TAC1—bipolar disorder	4.46e-05	0.00079	CbGpPWpGaD
Reboxetine—HTR2C—Signaling by GPCR—DRD1—bipolar disorder	4.38e-05	0.000775	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—IMPA1—bipolar disorder	4.33e-05	0.000766	CbGpPWpGaD
Reboxetine—HTR2C—GPCR downstream signaling—ADCY2—bipolar disorder	4.26e-05	0.000755	CbGpPWpGaD
Reboxetine—HTR2C—Signaling by GPCR—DRD3—bipolar disorder	4.24e-05	0.00075	CbGpPWpGaD
Reboxetine—HTR2C—GPCR downstream signaling—DRD2—bipolar disorder	4.22e-05	0.000747	CbGpPWpGaD
Reboxetine—HTR2C—GPCR ligand binding—POMC—bipolar disorder	4.18e-05	0.000739	CbGpPWpGaD
Reboxetine—HTR2C—Signaling by GPCR—DRD4—bipolar disorder	4.11e-05	0.000728	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—IMPA1—bipolar disorder	4.08e-05	0.000722	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—IMPA2—bipolar disorder	3.95e-05	0.000698	CbGpPWpGaD
Reboxetine—HTR2C—Signaling by GPCR—ADCY2—bipolar disorder	3.87e-05	0.000686	CbGpPWpGaD
Reboxetine—HTR2C—Signaling by GPCR—DRD2—bipolar disorder	3.83e-05	0.000678	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—NDUFV2—bipolar disorder	3.68e-05	0.000651	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—AKR1C4—bipolar disorder	3.56e-05	0.000631	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—TRPC3—bipolar disorder	3.48e-05	0.000616	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—NDUFV2—bipolar disorder	3.47e-05	0.000614	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—AKR1C4—bipolar disorder	3.36e-05	0.000594	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—ADM—bipolar disorder	3.32e-05	0.000587	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—PDE4B—bipolar disorder	3.23e-05	0.000572	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—TSHB—bipolar disorder	3.23e-05	0.000572	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—TACR1—bipolar disorder	3.23e-05	0.000572	CbGpPWpGaD
Reboxetine—ABCB1—Transmembrane transport of small molecules—SLC6A3—bipolar disorder	3.21e-05	0.000569	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—NR1D1—bipolar disorder	3.2e-05	0.000566	CbGpPWpGaD
Reboxetine—ABCB1—Transmembrane transport of small molecules—ADCY2—bipolar disorder	3.19e-05	0.000565	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—NCAN—bipolar disorder	3.06e-05	0.000542	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—NR1D1—bipolar disorder	3.02e-05	0.000534	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—SLC5A3—bipolar disorder	3e-05	0.000531	CbGpPWpGaD
Reboxetine—CYP3A4—Biological oxidations—POMC—bipolar disorder	2.98e-05	0.000528	CbGpPWpGaD
Reboxetine—HTR2C—GPCR downstream signaling—HTR2A—bipolar disorder	2.96e-05	0.000523	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—NCAN—bipolar disorder	2.88e-05	0.000511	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—SLC5A3—bipolar disorder	2.83e-05	0.0005	CbGpPWpGaD
Reboxetine—HTR2C—Signaling by GPCR—HTR2A—bipolar disorder	2.68e-05	0.000475	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—HTR1A—bipolar disorder	2.68e-05	0.000474	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—IMPA1—bipolar disorder	2.67e-05	0.000472	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—TAC1—bipolar disorder	2.64e-05	0.000467	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—DRD1—bipolar disorder	2.59e-05	0.000458	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—NTRK2—bipolar disorder	2.51e-05	0.000445	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—DRD3—bipolar disorder	2.5e-05	0.000443	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—GSK3A—bipolar disorder	2.49e-05	0.000441	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—DRD4—bipolar disorder	2.43e-05	0.00043	CbGpPWpGaD
Reboxetine—HTR2C—GPCR downstream signaling—POMC—bipolar disorder	2.36e-05	0.000418	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—ADCY2—bipolar disorder	2.29e-05	0.000405	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—TCF7L2—bipolar disorder	2.28e-05	0.000404	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—NDUFV2—bipolar disorder	2.27e-05	0.000401	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—DRD2—bipolar disorder	2.26e-05	0.000401	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—AKR1C4—bipolar disorder	2.19e-05	0.000388	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—CLOCK—bipolar disorder	2.17e-05	0.000384	CbGpPWpGaD
Reboxetine—HTR2C—Signaling by GPCR—POMC—bipolar disorder	2.14e-05	0.000379	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—TPH2—bipolar disorder	2.11e-05	0.000374	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—CACNB2—bipolar disorder	2.11e-05	0.000374	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—TSHB—bipolar disorder	2.11e-05	0.000374	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—DPYD—bipolar disorder	2.08e-05	0.000368	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—NTRK1—bipolar disorder	2.05e-05	0.000363	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—CLOCK—bipolar disorder	2.04e-05	0.000362	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—S100B—bipolar disorder	1.99e-05	0.000353	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—TSHB—bipolar disorder	1.99e-05	0.000352	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—CACNB2—bipolar disorder	1.99e-05	0.000352	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—TPH2—bipolar disorder	1.99e-05	0.000352	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—NR1D1—bipolar disorder	1.97e-05	0.000349	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—DPYD—bipolar disorder	1.96e-05	0.000347	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—CACNA1C—bipolar disorder	1.93e-05	0.000342	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—NCAN—bipolar disorder	1.89e-05	0.000334	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—PIK3C2A—bipolar disorder	1.88e-05	0.000333	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—SLC5A3—bipolar disorder	1.85e-05	0.000327	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—CACNA1C—bipolar disorder	1.82e-05	0.000322	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—PIK3C2A—bipolar disorder	1.77e-05	0.000314	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—NRG1—bipolar disorder	1.76e-05	0.000311	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—SNAP25—bipolar disorder	1.69e-05	0.000299	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—SNAP25—bipolar disorder	1.59e-05	0.000282	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—HTR2A—bipolar disorder	1.59e-05	0.000281	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—ADCY2—bipolar disorder	1.49e-05	0.000265	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—ADCY2—bipolar disorder	1.41e-05	0.000249	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—CLOCK—bipolar disorder	1.34e-05	0.000236	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—TSHB—bipolar disorder	1.3e-05	0.00023	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—TPH2—bipolar disorder	1.3e-05	0.00023	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—CACNB2—bipolar disorder	1.3e-05	0.00023	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—DPYD—bipolar disorder	1.28e-05	0.000227	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—COMT—bipolar disorder	1.28e-05	0.000227	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—GSK3B—bipolar disorder	1.28e-05	0.000226	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—MAOA—bipolar disorder	1.27e-05	0.000225	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—POMC—bipolar disorder	1.27e-05	0.000224	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—INS—bipolar disorder	1.26e-05	0.000223	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—COMT—bipolar disorder	1.21e-05	0.000213	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—MAOA—bipolar disorder	1.2e-05	0.000212	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—CACNA1C—bipolar disorder	1.19e-05	0.000211	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—PIK3C2A—bipolar disorder	1.16e-05	0.000205	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—SNAP25—bipolar disorder	1.04e-05	0.000184	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—MTHFR—bipolar disorder	1.03e-05	0.000183	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—MTHFR—bipolar disorder	9.75e-06	0.000173	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—ADCY2—bipolar disorder	9.21e-06	0.000163	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—POMC—bipolar disorder	8.27e-06	0.000146	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—INS—bipolar disorder	8.23e-06	0.000146	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—COMT—bipolar disorder	7.89e-06	0.00014	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—MAOA—bipolar disorder	7.83e-06	0.000139	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—POMC—bipolar disorder	7.8e-06	0.000138	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—INS—bipolar disorder	7.75e-06	0.000137	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—MTHFR—bipolar disorder	6.37e-06	0.000113	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—POMC—bipolar disorder	5.1e-06	9.02e-05	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—INS—bipolar disorder	5.07e-06	8.97e-05	CbGpPWpGaD
